280 related articles for article (PubMed ID: 29575529)
1. Podoplanin: An emerging cancer biomarker and therapeutic target.
Krishnan H; Rayes J; Miyashita T; Ishii G; Retzbach EP; Sheehan SA; Takemoto A; Chang YW; Yoneda K; Asai J; Jensen L; Chalise L; Natsume A; Goldberg GS
Cancer Sci; 2018 May; 109(5):1292-1299. PubMed ID: 29575529
[TBL] [Abstract][Full Text] [Related]
2. Roles of Podoplanin in Malignant Progression of Tumor.
Suzuki H; Kaneko MK; Kato Y
Cells; 2022 Feb; 11(3):. PubMed ID: 35159384
[TBL] [Abstract][Full Text] [Related]
3. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
Suchanski J; Tejchman A; Zacharski M; Piotrowska A; Grzegrzolka J; Chodaczek G; Nowinska K; Rys J; Dziegiel P; Kieda C; Ugorski M
PLoS One; 2017; 12(9):e0184970. PubMed ID: 28938000
[TBL] [Abstract][Full Text] [Related]
4. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
[TBL] [Abstract][Full Text] [Related]
5. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
Front Immunol; 2021; 12():807600. PubMed ID: 34987523
[TBL] [Abstract][Full Text] [Related]
6. Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.
Tejchman A; Lamerant-Fayel N; Jacquinet JC; Bielawska-Pohl A; Mleczko-Sanecka K; Grillon C; Chouaib S; Ugorski M; Kieda C
Oncotarget; 2017 May; 8(19):31876-31887. PubMed ID: 28416768
[TBL] [Abstract][Full Text] [Related]
7. Podoplanin in Inflammation and Cancer.
Quintanilla M; Montero-Montero L; Renart J; Martín-Villar E
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736372
[TBL] [Abstract][Full Text] [Related]
8. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility.
Krishnan H; Ochoa-Alvarez JA; Shen Y; Nevel E; Lakshminarayanan M; Williams MC; Ramirez MI; Miller WT; Goldberg GS
J Biol Chem; 2013 Apr; 288(17):12215-21. PubMed ID: 23530051
[TBL] [Abstract][Full Text] [Related]
9. PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility.
Krishnan H; Retzbach EP; Ramirez MI; Liu T; Li H; Miller WT; Goldberg GS
Exp Cell Res; 2015 Jul; 335(1):115-22. PubMed ID: 25959509
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.
Lee HY; Yu NY; Lee SH; Tsai HJ; Wu CC; Cheng JC; Chen DP; Wang YR; Tseng CP
Biomed J; 2020 Apr; 43(2):146-162. PubMed ID: 32441651
[TBL] [Abstract][Full Text] [Related]
11. Expression of Podoplanin in Mammary Cancers in Female Dogs.
Borecka P; Ciaputa R; Janus I; Piotrowska A; Ratajczak-Wielgomas K; Kmiecik A; Podhorska-Okolów M; Dzięgiel P; Nowak M
In Vivo; 2020; 34(1):213-223. PubMed ID: 31882481
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin promotes the carcinogenicity of gastric cancer by activating ezrin and mediating the crosstalk between tumour cells and cancer-associated fibroblasts.
Tian Y; Chen X; Wang X; Song Y
Exp Physiol; 2023 May; 108(5):740-751. PubMed ID: 36156321
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas.
Shindo K; Aishima S; Ohuchida K; Fujiwara K; Fujino M; Mizuuchi Y; Hattori M; Mizumoto K; Tanaka M; Oda Y
Mol Cancer; 2013 Dec; 12(1):168. PubMed ID: 24354864
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation.
Takeuchi S; Fukuda K; Yamada T; Arai S; Takagi S; Ishii G; Ochiai A; Iwakiri S; Itoi K; Uehara H; Nishihara H; Fujita N; Yano S
Cancer Sci; 2017 Apr; 108(4):696-703. PubMed ID: 28182302
[TBL] [Abstract][Full Text] [Related]
16. A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.
Feng C; Yu A; Wang Z; Wang K; Chen J; Wu Y; Deng T; Chen H; Hou Y; Ma S; Dai X; Huang L
J Exp Clin Cancer Res; 2024 Jan; 43(1):9. PubMed ID: 38167452
[TBL] [Abstract][Full Text] [Related]
17. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
Suzuki J; Aokage K; Neri S; Sakai T; Hashimoto H; Su Y; Yamazaki S; Nakamura H; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Ishii G
Lung Cancer; 2021 Mar; 153():1-10. PubMed ID: 33429158
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation.
Carrasco-Ramírez P; Greening DW; Andrés G; Gopal SK; Martín-Villar E; Renart J; Simpson RJ; Quintanilla M
Oncotarget; 2016 Mar; 7(13):16070-89. PubMed ID: 26893367
[TBL] [Abstract][Full Text] [Related]
19. Correlation Between Expression of Twist and Podoplanin in Ductal Breast Carcinoma.
Grzegrzolka J; Wojtyra P; Biala M; Piotrowska A; Gomulkiewicz A; Rys J; Podhorska-Okolow M; Dziegiel P
Anticancer Res; 2017 Oct; 37(10):5485-5493. PubMed ID: 28982860
[TBL] [Abstract][Full Text] [Related]
20. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
